Join to access to all OVN content. Join for Free
The Value of Social Listening for MSL Success
social listening MSL success digital strategy innovation healthcare professionals

The Value of Social Listening for MSL Success


Share This Article


Summary

My guests this week are Vandana Grover, Sr Director, Head of Digital Strategy and Innovation at Eisai and Stevan Tomich, Lead Omni Channel Strategist at AbbVie who discuss the value of social listening for MSL success.

Key Points

  • Understanding and leveraging social listening can significantly enhance an MSL's ability to stay informed about HCPs' perceptions, treatment preferences, and emerging data trends.
  • Being adept at social listening allows MSLs to gather real-time insights and sentiment analysis from HCPs and patients, which can be invaluable for pre-call planning and strategic engagement.
  • MSLs should be cautious to adhere to their company's compliance guidelines, focusing more on listening rather than engaging directly with HCPs and patients on social media platforms.

Click for Source
social listening, MSL success, digital strategy, innovation, healthcare professionals

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
OVN Avatar Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Article
Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?
Partner Avatar Envision Pharma Group

Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Press Release
Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology
OVN Avatar Joe Pardavila sits down with Dr. Ramin Farhood and Dr. Kirk Shepard

Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
OVN Avatar OVN Staff

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

Explore OVN